[Effectiveness and tolerance of Sedalipid in the treatment of hyperlipoproteinemias].
D002986:Clinical Trials as Topic; D005260:Female; D005973:Glutamine / Q000627:therapeutic use*; D006801:Humans; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D005973:Glutamine; D011732:Pyridoxal Phosphate; C047672:magnesium-pyridoxal-5'-phosphate glutamate
Wirksamkeit und Verträglichkeit von Sedalipid bei der Behandlung von Hyperlipoproteinämien.